SIO_290857-18_MasterClass_WB_728x90.jpg

Master Class 2018

» Program

» Faculty

Registration

» Registration

Hotel & Travel

» Hotel

» Explore Chicago

Master Class Program: Catheter Directed Therapy for the New IR/IO Practice

*Details are subject to change

November 10, 2018

Time

Title

7:30-8:00

Breakfast

8:00-8:20

Lymphatic Interventions: When, How and Why?

Maxim Itkin, MD

8:20-8:40

Lymphatic Interventions: How I Do It

Gregory J. Nadolski, MD

8:40-9:00

Break

9:00-9:20

Patient Selection for cTACE

Kenneth Kolbeck, MD, PhD

9:20-9:40

How and When to Say ‘No’: When Does Liver or Tumor Status Make Treatment Futile

Samdeep K. Mouli, MD

9:40-10:00

Should I Do a Biopsy? Impact of HCC Histology/Genetics on Risk Stratification, Therapy Allocation, and Clinical Outcomes

Rahul Sheth, MD

10:00-10:20

cTACE Mechanism of Action: What Really Happens When I Embolize?

Stephen Hunt, MD, PhD

10:20-10:45

cTACE Technique: Catheterization, Emulsification, and Delivery - How I Do It

Michael C. Soulen, MD

10:45-11:00

Combination Therapies: cTACE and Ablation/cTACE and Systemic Therapy - When and How?

Khashayar Farsad, MD, PhD

11:00-11:20

Peri- and Post-Procedural Care

Susan Shamimi-Noori, MD

11:20-11:30

Q&A

11:30-12:45

Hands on Workshop

William Rilling, MD

Sarah White, MD, MS

12:45-14:00

Lunch

14:00-14:20

Outcomes of Embolotherapy for HCC

F. Edward Boas, MD, PhD

14:20-14:40

Outcomes of Embolotherapy for mNET

Michael C. Soulen, MD

14:40-15:00

Outcomes of Embolotherapy for Other Cancers

David C. Madoff, MD

15:00-15:20

Choosing Among Embolotherapies: cTACE vs. DEB/TAE

William Rilling, MD

15:20-15:40

Choosing Among Embolotherapies: cTACE vs. TARE

Ryan Hickey, MD

15:40-16:00

Q&A

16:00-17:00

Meet the Experts: Second Opinion

Muneeb Ahmed, MD

David C. Madoff, MD

Gregory J. Nadolski, MD

17:00-19:00

Break

19:00-22:00

Dinner

November 11, 2018

Time

Title

7:30-8:00

Breakfast

8:00-8:20

Advanced Intra-Procedural Imaging

Rony Avritscher, MD

8:20-8:40

Best Practices in Imaging Response Assessment after LRT

Khashayar Farsad, MD, PhD

8:40-9:40

Case-based Bad Outcomes: Avoidable?

Muneeb Ahmed, MD

Ryan Hickey, MD

Samdeep K. Mouli, MD

Sarah White, MD

9:40-10:00

Prognostic Imaging/Clinical/Laboratory Biomarkers in Liver Cancer Therapies

Julius Chapiro, MD, PhD

10:00-10:30

Break

10:30-11:30

Case-based, Embolotherapy: Challenging Anatomy, Arterio-Porta/Heptopulmonary Shunting, and Portal Vein Thrombus - What to Do?

F. Edward Boas, MD, PhD

Kenneth Kolbeck, MD, PhD

Gregory J. Nadolski, MD

Hooman Yarmohammadi, MD

11:30-11:50

Starting an Interventional Oncology Program

Sarah White, MD

11:40-12:00

Q&A